BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4154860)

  • 1. Structure-selectivity relationships of beta-adrenoceptor antagonists in cats.
    Zakhari S
    Eur J Pharmacol; 1974 Nov; 29(1):22-9. PubMed ID: 4154860
    [No Abstract]   [Full Text] [Related]  

  • 2. Assessment of selective beta-adrenoceptor blockade in man.
    Briant RH; Dollery CT; Fenyvesi T; George CF
    Br J Pharmacol; 1973 Sep; 49(1):106-14. PubMed ID: 4150760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of peripheral vascular responses to isoprenaline by three beta-adrenoceptor antagonists in the anaesthetized dog.
    Hainsworth R; Karim F; Stoker JB
    Br J Pharmacol; 1974 Jun; 51(2):161-8. PubMed ID: 4155969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Structure-activity relationship of phenoxyalkanolamine derivatives with selective beta 1-receptor blocking action].
    Femmer K
    Pharmazie; 1975 Oct; 30(10):638-42. PubMed ID: 687
    [No Abstract]   [Full Text] [Related]  

  • 5. Beta-adrenoceptor blocking agents. 1. Cardioselective 1-aryloxy-3-(aryloxyalkylamino)propan-2-ols.
    Augstein J; Cox DA; Ham AL; Leeming PR; Snarey M
    J Med Chem; 1973 Nov; 16(11):1245-51. PubMed ID: 4147835
    [No Abstract]   [Full Text] [Related]  

  • 6. Analysis of the actions of alprenolol and propranolol on the beta adrenergic receptors controlling heart rate in the anaesthetized cat.
    Ablad B; Brändström A; Ek L; Sjölander M
    Eur J Pharmacol; 1971 May; 14(4):319-32. PubMed ID: 4400533
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparative study of the activity of beta-adrenoceptor antagonists in man.
    Taylor SH; Thadani U; Davidson C; singleton W; Myint S
    Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):305-6. PubMed ID: 240783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of beta-adrenolytic properties of N,N'-bis-(3-(p-methoxyphenoxy)-2-hydroxypropyl)-ethylenediamine and its N,N'-dimethyl derivative.
    Robak J; Grodzińska L
    Pol J Pharmacol Pharm; 1973; 25(3):253-7. PubMed ID: 4150018
    [No Abstract]   [Full Text] [Related]  

  • 9. beta-Adrenergic blocking agents. 23. 1-[Substituted-amido)phenoxy]-3-[[(substituted-amido)alkyl]amino] propan-2-ols.
    Large MS; Smith LH
    J Med Chem; 1983 Mar; 26(3):352-7. PubMed ID: 6131134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The actions of a new beta-adrenoceptor blocking drug, ICI 66082, on the rabbit papillary muscle and on the dog heart.
    Harry JD; Knapp MF; Linden RJ
    Br J Pharmacol; 1974 Jun; 51(2):169-77. PubMed ID: 4155970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cardiovascular activity of 2-amino-5-(3,4-dichlorophenoxymethyl)-2-oxazoline (APMO).
    Abdallah AH; White HD
    Toxicol Appl Pharmacol; 1973 Dec; 26(4):513-22. PubMed ID: 4149198
    [No Abstract]   [Full Text] [Related]  

  • 12. Reflex beta-adrenergic vasodilatation in the cat.
    Tuttle RS; Moe GK
    Am J Physiol; 1973 Aug; 225(2):402-7. PubMed ID: 4146613
    [No Abstract]   [Full Text] [Related]  

  • 13. Haemodynamic and coronary vascular responses after beta-adrenoceptor blockade in the anaesthetised dog: a comparison of tolamolol with practolol and propranolol.
    Adam KR; Boyles SM
    Eur J Pharmacol; 1974 Apr; 26(1):96-107. PubMed ID: 4151643
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiac action of carazolol and methypranol in comparison with other beta-receptor blockers.
    Bartsch W; Dietmann K; Leinert H; Sponer G
    Arzneimittelforschung; 1977; 27(5):1022-6. PubMed ID: 18157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in beta-adrenoceptor-blocking activity produced by chemical modifications in the practolol molecule.
    Weinstock M; Schechter Y; Erez M; Shtacher G
    Eur J Pharmacol; 1974 May; 26(2):191-7. PubMed ID: 4152806
    [No Abstract]   [Full Text] [Related]  

  • 16. Proceedings: The efferent pathway of the reflex increase in heart rate produced by stimulation of left arterial receptors.
    Kappagoda CT; Linden RJ; Scott EM; Snow HM
    J Physiol; 1974 Oct; 242(2):79P-80P. PubMed ID: 4156368
    [No Abstract]   [Full Text] [Related]  

  • 17. Prediction of the non-specific cardiodepressant effects of beta-adrenoceptor blocking agents in vitro and in vivo by means of the Hansch analysis.
    Hellenbrecht D; Grobecker H; Müller KF
    Eur J Pharmacol; 1974 Dec; 29(2):223-5. PubMed ID: 4155366
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of beta-adrenergic blocking activities of propranolol, isopropylmethoxamine, sotalol, practolol, alprenolol, pindolol, oxprenolol and D-32 in the atria and trachea of the guinea-pig.
    Horii D; Kawada T; Takeda K; Imai S
    Arzneimittelforschung; 1974 Sep; 24(9):1275-7. PubMed ID: 4154764
    [No Abstract]   [Full Text] [Related]  

  • 19. Central actions of some beta-adrenoceptor blocking agents.
    Shah UH; Jindal MN; Patel VK; Kelkar VV
    Arzneimittelforschung; 1974 Oct; 24(10):1581-4. PubMed ID: 4154760
    [No Abstract]   [Full Text] [Related]  

  • 20. Nitrilophenoxypropanolamines: influence of ring substitution on beta-receptor blockade.
    Mylecharane EJ; Raper C
    Eur J Pharmacol; 1974 Nov; 29(1):93-101. PubMed ID: 4154862
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.